Implication of SARS-CoV-2 Immune Escape Spike Variants on Secondary and Vaccine Breakthrough Infections
出版年份 2021 全文链接
标题
Implication of SARS-CoV-2 Immune Escape Spike Variants on Secondary and Vaccine Breakthrough Infections
作者
关键词
-
出版物
Frontiers in Immunology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-11-03
DOI
10.3389/fimmu.2021.742167
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Advances in Immunotherapy for COVID-19: a comprehensive review
- (2021) Masoumeh Masoumi Karimi et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- No higher infectivity but immune escape of SARS-CoV-2 501Y.V2 variants
- (2021) Qianqian Li et al. CELL
- Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study
- (2021) Matthew K Hensley et al. CLINICAL INFECTIOUS DISEASES
- Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers
- (2021) Letícia Adrielle dos Santos et al. JOURNAL OF INFECTION
- S-variant SARS-CoV-2 lineage B1.1.7 is associated with significantly higher viral loads in samples tested by ThermoFisher TaqPath RT-qPCR
- (2021) Michael Kidd et al. JOURNAL OF INFECTIOUS DISEASES
- SARS-CoV-2 spike D614G change enhances replication and transmission
- (2021) Bin Zhou et al. NATURE
- Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
- (2021) Dami A. Collier et al. NATURE
- SARS-CoV-2 evolution during treatment of chronic infection
- (2021) Steven A. Kemp et al. NATURE
- SARS-CoV-2 within-host diversity and transmission
- (2021) Katrina A. Lythgoe et al. SCIENCE
- Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
- (2021) Xianding Deng et al. CELL
- Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351)
- (2021) Thandeka Moyo-Gwete et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccine Breakthrough Infections with SARS-CoV-2 Variants
- (2021) Ezgi Hacisuleyman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Postvaccination SARS‐CoV‐2 infections among skilled nursing facility residents and staff members — Chicago, Illinois, December 2020–March 2021
- (2021) Richard A. Teran et al. AMERICAN JOURNAL OF TRANSPLANTATION
- SARS-CoV-2 reinfection with a virus harboring mutation in the Spike and the Nucleocapsid proteins in Panama
- (2021) Yamilka Díaz et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India
- (2021) Beena Philomina J et al. JOURNAL OF INFECTION
- Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination
- (2021) Adeel A. Butt et al. JOURNAL OF INFECTION
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
- (2021) Delphine Planas et al. NATURE
- Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals
- (2021) Talia Kustin et al. NATURE MEDICINE
- SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
- (2021) Matthew McCallum et al. SCIENCE
- Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies
- (2021) Marta Alenquer et al. PLoS Pathogens
- N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2
- (2021) Fang Tian et al. eLife
- COVID-19 Vaccine Breakthrough Infections Reported to CDC — United States, January 1–April 30, 2021
- (2021) et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution
- (2021) Jiří Zahradník et al. Nature Microbiology
- Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients
- (2020) Zijie Shen et al. CLINICAL INFECTIOUS DISEASES
- Deployment of convalescent plasma for the prevention and treatment of COVID-19
- (2020) Evan M. Bloch et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China
- (2020) Yanrong Wang et al. JOURNAL OF INFECTIOUS DISEASES
- Virological assessment of hospitalized patients with COVID-2019
- (2020) Roman Wölfel et al. NATURE
- The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
- (2020) Qianqian Li et al. CELL
- Mutations Strengthened SARS-CoV-2 Infectivity
- (2020) Jiahui Chen et al. JOURNAL OF MOLECULAR BIOLOGY
- Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
- (2020) Luca Piccoli et al. CELL
- Asymptomatic Reinfection in 2 Healthcare Workers From India With Genetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2
- (2020) Vivek Gupta et al. CLINICAL INFECTIOUS DISEASES
- Identification of a polymorphism in the N gene of SARS-CoV-2 that adversely impacts detection by RT-PCR.
- (2020) Manu Vanaerschot et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Treatment for COVID-19: An overview
- (2020) Cristina Stasi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
- (2020) Bina Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
- (2020) Sheila F. Lumley et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started